Abstract
In order to elucidate the effect of long-term treatment with CPIB on the ultrastructure of the human liver, we measured the numerical and volume density of mitochondria and peroxisomes per cm 3 of liver tissue by morphometric procedures before and during prolonged intake of the drug in 16 patients with primary hypertriglyceridemia. We correlated the number and volume of mitochondria and peroxisomes to serum triglyceride and cholesterol concentrations and changes in order to obtain information on the interrelationship of organelle changes and lipid-lowering action. CPIB treatment resulted in significant increases in the numerical density of mitochondria and peroxisomes (38% and 50%, respectively, P < 0.01). The volume density for mitochondria and peroxisomes increased by 34% ( P < 0.01) and 23% (NS) respectively. After a marked proliferation of both organelles during the first months no further significant increase was observed. The fall in triglyceride and cholesterol levels during the initial period was followed by constant concentrations. A significant correlation between numerical and volume density of mitochondria and peroxisomes occurred during treatment indicating a well-balanced adapted process. There was a significant reverse correlation between the increase in volume density of mitochondria and the decrease in triglyceride levels, whereas no relation between the proliferation of peroxisomes and hypolipidemic action existed. In our study long-term treatment with CPIB had no toxic or carcinogenic effects on the human liver. Contrary to the fine structural changes in the rodents, the proliferation of peroxisomes is less pronounced and proportional to the increase in mitochondria. The correlation between mitochondrial proliferation and the triglyceride-lowering effect supports the hypothesis that CPIB reduces hepatic triglyceride synthesis by an increase in mitochondria associated with elevated activity of glycerol-3-phosphate dehydrogenase.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.